WO2010078833A8 - 一种改性钠基蒙脱石、其制备方法和用途 - Google Patents

一种改性钠基蒙脱石、其制备方法和用途 Download PDF

Info

Publication number
WO2010078833A8
WO2010078833A8 PCT/CN2010/000032 CN2010000032W WO2010078833A8 WO 2010078833 A8 WO2010078833 A8 WO 2010078833A8 CN 2010000032 W CN2010000032 W CN 2010000032W WO 2010078833 A8 WO2010078833 A8 WO 2010078833A8
Authority
WO
WIPO (PCT)
Prior art keywords
montmorillonite
modified
preparing method
modified sodium
nanometer
Prior art date
Application number
PCT/CN2010/000032
Other languages
English (en)
French (fr)
Other versions
WO2010078833A1 (zh
Inventor
郑海辉
吕光烈
夏志国
徐年
乐盛
马忠朝
迟玉峰
陈文波
陈积馨
Original Assignee
浙江海力生制药有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 浙江海力生制药有限公司 filed Critical 浙江海力生制药有限公司
Priority to US13/143,830 priority Critical patent/US9095542B2/en
Priority to EP10729092.6A priority patent/EP2380850B1/en
Priority to JP2011544776A priority patent/JP5718252B2/ja
Priority to KR1020117018246A priority patent/KR101295204B1/ko
Publication of WO2010078833A1 publication Critical patent/WO2010078833A1/zh
Publication of WO2010078833A8 publication Critical patent/WO2010078833A8/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
    • B01J20/12—Naturally occurring clays or bleaching earth
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
    • B01J20/28004—Sorbent size or size distribution, e.g. particle size
    • B01J20/28007—Sorbent size or size distribution, e.g. particle size with size in the range 1-100 nanometers, e.g. nanosized particles, nanofibers, nanotubes, nanowires or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/14—Base exchange silicates, e.g. zeolites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/20—Silicates
    • C01B33/36—Silicates having base-exchange properties but not having molecular sieve properties
    • C01B33/38—Layered base-exchange silicates, e.g. clays, micas or alkali metal silicates of kenyaite or magadiite type
    • C01B33/40—Clays
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK  ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
    • C09C1/00—Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
    • C09C1/40—Compounds of aluminium
    • C09C1/42—Clays
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/60—Particles characterised by their size
    • C01P2004/62—Submicrometer sized, i.e. from 0.1-1 micrometer
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/60—Particles characterised by their size
    • C01P2004/64—Nanometer sized, i.e. from 1-100 nanometer
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/80—Compositional purity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Nanotechnology (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Epidemiology (AREA)
  • Composite Materials (AREA)
  • General Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
PCT/CN2010/000032 2009-01-08 2010-01-08 一种改性钠基蒙脱石、其制备方法和用途 WO2010078833A1 (zh)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/143,830 US9095542B2 (en) 2009-01-08 2010-01-08 Modified sodium-montmorillonite, preparation method and uses thereof
EP10729092.6A EP2380850B1 (en) 2009-01-08 2010-01-08 Modified sodium-montmorillonite, preparing method and uses thereof
JP2011544776A JP5718252B2 (ja) 2009-01-08 2010-01-08 修飾ナトリウムモンモリロナイト、その調製方法及び使用
KR1020117018246A KR101295204B1 (ko) 2009-01-08 2010-01-08 개질된 소듐-몬모릴로나이트, 그의 제조 방법 및 용도

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200910001369.3 2009-01-08
CN200910001369 2009-01-08

Publications (2)

Publication Number Publication Date
WO2010078833A1 WO2010078833A1 (zh) 2010-07-15
WO2010078833A8 true WO2010078833A8 (zh) 2010-10-07

Family

ID=42316255

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2010/000032 WO2010078833A1 (zh) 2009-01-08 2010-01-08 一种改性钠基蒙脱石、其制备方法和用途

Country Status (5)

Country Link
US (1) US9095542B2 (zh)
EP (1) EP2380850B1 (zh)
JP (1) JP5718252B2 (zh)
KR (1) KR101295204B1 (zh)
WO (1) WO2010078833A1 (zh)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102513201B (zh) * 2011-12-19 2014-07-30 浙江三鼎科技有限公司 一种蒙脱石超细粉体的制备方法
DE102012209411A1 (de) * 2012-06-04 2013-12-05 Fim Biotech Gmbh Mineralische Verbindung zur Reduzierung von anorganischen Phosphaten, insbesondere im Rahmen einer Nierenersatztherapie
US9790416B2 (en) * 2012-10-30 2017-10-17 Halliburton Energy Services, Inc. Drilling fluid compositions and methods for use thereof in subterranean formations
CN103848430B (zh) * 2012-11-29 2016-04-06 中国地质大学（北京） 一种从钙基膨润土中分离提纯蒙脱石的方法
CN103251648B (zh) * 2013-05-15 2015-08-05 乔敏 治疗血磷酸盐过多症及缺铁性贫血症的铁基蒙脱石药物及其制备方法
CN104593762A (zh) * 2014-12-30 2015-05-06 芜湖协诚金属制品有限公司 一种奥氏体304钣金加工时的防护方法
JP6535540B2 (ja) * 2015-08-03 2019-06-26 クニミネ工業株式会社 リチウム固定型有機修飾モンモリロナイトの製造方法
CN105203463B (zh) * 2015-09-10 2018-01-05 北京师范大学 基于偏振光显微镜观察蒙脱石吸附脂质的直观检测方法
US11344491B2 (en) 2015-09-23 2022-05-31 The Regents Of The University Of California Compositions and methods of using the same for decontamination of skin
CN108295808A (zh) * 2018-03-15 2018-07-20 阳原县仁恒精细粘土有限责任公司 一种造纸污水处理剂
CN108751765B (zh) * 2018-07-16 2020-10-02 东南大学 一种磷酸盐水泥缓凝剂及其使用方法
CN109250725B (zh) * 2018-08-20 2020-06-23 杭州柏科立新材料有限公司 一种利用膨润土精制蒙脱石生产工艺
CN109809422B (zh) * 2019-02-27 2021-07-06 北京中蓝港湾科技有限公司 一种提纯凹凸棒土的方法
CN110357118B (zh) * 2019-08-29 2021-08-13 苏州中材非金属矿工业设计研究院有限公司 一种膨润土制备无机凝胶的低能耗生产工艺
CN110694073A (zh) * 2019-10-21 2020-01-17 南通大学附属医院 一种载药长循环改性纳米蒙脱土材料及其制备方法
CN111017943B (zh) * 2019-12-03 2022-11-04 浙江工业大学之江学院 一种利用菱镁矿尾矿制备镁皂石的方法
CN110862092B (zh) * 2019-12-05 2021-03-16 长沙理工大学 一种机械球磨法制备聚多巴胺修饰蒙脱土纳米材料的方法
CN111269606B (zh) * 2020-03-06 2022-04-29 浙江丰虹新材料股份有限公司 一种用于水性涂料领域的高纯高增稠易分散纳米蒙脱石及其制备方法
CN111470514A (zh) * 2020-04-14 2020-07-31 蚌埠学院 一种钙基膨润土的改性方法
CN111589418B (zh) * 2020-06-02 2022-09-23 唐山师范学院 膨润土/膨胀石墨复合吸附剂及其制备方法和应用
CN111871387A (zh) * 2020-06-30 2020-11-03 西北大学 一种复合改性蒙脱土吸附剂、制备方法及其应用
CN111849215A (zh) * 2020-07-29 2020-10-30 上海万照精细化工有限公司 一种自分散的分散组合物的制备方法
CN112759808A (zh) * 2021-01-20 2021-05-07 戚皎珺 一种医用检查手套用丁腈胶乳及其制备方法
CN112794336A (zh) * 2021-01-29 2021-05-14 海南海力制药有限公司 蒙脱石的纯化方法、蒙脱石散及其制备方法
CN113358680B (zh) * 2021-06-01 2022-04-22 中国科学院地质与地球物理研究所 一种区分和半定量分析地质样品中不同类型蒙脱石的方法和应用
CN115463094B (zh) * 2021-06-10 2023-07-04 北京微著新材科技有限公司 一种口服放疗防护剂及其制备方法和应用
CN113425696B (zh) * 2021-07-02 2022-09-02 上海耀大生物科技有限公司 一种复方口服补液盐的泡腾制剂及其制备工艺和应用
KR102561522B1 (ko) 2021-08-19 2023-08-02 건국대학교 산학협력단 양이온 표면개질 점토광물 흡착제 및 그 제조방법
CN113797885A (zh) * 2021-09-07 2021-12-17 广东省科学院生态环境与土壤研究所 一种有机改性蒙脱石复合材料及其应用
CN114306708B (zh) * 2021-12-28 2023-01-03 山东中大药业有限公司 一种含蒙脱石的成人纸尿裤
CN114288985A (zh) * 2021-12-29 2022-04-08 浙江工业大学 一种黑滑石吸附材料及其制备方法与应用
CN114314602A (zh) * 2022-01-20 2022-04-12 北京桃古图生物科技有限公司 一种饲料用蒙脱石粘结剂及其制备方法
CN114470288B (zh) * 2022-03-14 2023-08-22 浙江宋朝臻选科技有限公司 具有舒缓作用的香氛及其制备方法
CN114561057B (zh) * 2022-03-29 2023-09-22 安徽钰泽塑业科技有限公司 一种环保型pe改性颗粒及其制备方法
CN114747676A (zh) * 2022-05-06 2022-07-15 山东省畜牧总站(山东省种畜禽质量测定站) 一种提高肉牛繁殖效率的生物工艺及其组合物
CN115231581B (zh) * 2022-07-13 2023-08-18 中国地质大学（武汉） 一种去除膨润土中方石英并同步制备医药级蒙脱石的方法
WO2024092534A1 (zh) * 2022-11-02 2024-05-10 浙江丰虹新材料股份有限公司 一种用于水性涂料领域的高纯高增稠易分散纳米蒙脱石及其制备方法
CN116473873B (zh) * 2023-03-07 2023-10-20 广西瑞云化工科技有限公司 一种牙膏用增稠保湿材料的制备方法及其产品和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3693412A (en) * 1971-03-18 1972-09-26 George L Kalousek Method for measuring thixotropy
JPS6270222A (ja) * 1985-09-24 1987-03-31 Kunimine Kogyo Kk 水簸ベントナイトの製造方法
JPS6350310A (ja) * 1986-08-14 1988-03-03 Mizusawa Ind Chem Ltd 活性ベントナイト及びその製法
DE3886239D1 (de) * 1987-03-13 1994-01-27 Redco Nv Thixotropisches Additiv, Verfahren zu seiner Herstellung und seine Benützung.
GB9110883D0 (en) * 1991-05-20 1991-07-10 Ici Plc Highly filled,polymerisable compositions
JPH08277108A (ja) * 1995-04-06 1996-10-22 Fine Kurei:Kk 精製ベントナイトの製造方法
JPH10194726A (ja) * 1997-01-09 1998-07-28 Mizusawa Ind Chem Ltd 長期保存性に優れた高濃度ベントナイト水性スラリー、その用途及びその使用方法
WO2000000456A1 (en) * 1998-06-30 2000-01-06 Eastman Chemical Company Preparation of an aldol using a base-modified clay catalyst
KR20040088125A (ko) * 2003-04-08 2004-10-16 김우성 솔리토늄이 함유된 체중감량용 원단 및 그 용도
FR2875405B1 (fr) * 2004-09-17 2007-01-19 Sod Conseils Rech Applic Procede de purification d'une argile
CN100513311C (zh) 2005-11-04 2009-07-15 浙江海力生制药有限公司 改性蒙脱石及其制备方法和其应用
CN1957948A (zh) * 2005-11-04 2007-05-09 浙江海力生制药有限公司 改性蒙脱石及其制备方法和其应用
CN101016157A (zh) 2006-02-09 2007-08-15 浙江海力生制药有限公司 提纯蒙脱石的方法和提纯蒙脱石及其组合物
WO2007051427A1 (fr) 2005-11-04 2007-05-10 Zhejiang Hailisheng Pharmaceutical Limited Co. Montmorillonite modifiee, son procede de preparation et ses utilisations
CN101002796B (zh) * 2006-01-18 2010-11-10 浙江海力生制药有限公司 纳米蒙脱石在制药中的应用及其药物组合物
CN101602509B (zh) 2008-06-11 2013-08-07 浙江海力生制药有限公司 一种利用电泳提纯蒙脱石的方法及其制得的蒙脱石和其应用

Also Published As

Publication number Publication date
EP2380850A1 (en) 2011-10-26
JP5718252B2 (ja) 2015-05-13
EP2380850A4 (en) 2012-06-13
KR20110114618A (ko) 2011-10-19
KR101295204B1 (ko) 2013-08-09
JP2012514571A (ja) 2012-06-28
EP2380850B1 (en) 2016-10-19
WO2010078833A1 (zh) 2010-07-15
US20120003328A1 (en) 2012-01-05
US9095542B2 (en) 2015-08-04

Similar Documents

Publication Publication Date Title
WO2010078833A8 (zh) 一种改性钠基蒙脱石、其制备方法和用途
EP2201115A4 (en) MUTANTS FOR PRODUCING 1,4-BUTANEDIOL AND PROCESS FOR THE PRODUCTION OF 1,4-BUTANEDIOL USING SUCH MUTANTS
WO2009114601A3 (en) Preparation of lenalidomide
WO2007121443A3 (en) Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
WO2009134492A3 (en) Functionalized graphene sheets having high carbon to oxygen ratios
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
WO2011057706A8 (de) Materialien für elektronische vorrichtungen
WO2003078315A3 (en) Nanocomposites: products, process for obtaining them and uses thereof
WO2011060304A3 (en) Oxygen scavengers, compositions comprising the scavengers, and artcles made from the compositions
WO2010014406A8 (en) A novel molecular sieve composition emm-13, a method of making and a process of using the same
WO2008070692A3 (en) Bicyclic compounds and use as antidiabetics
SG159474A1 (en) Conjugated diene polymer, conjugated diene polymer composition, and method for producing conjugated diene polymer
WO2010091790A8 (en) A compound material comprising a metal and nanoparticles and a method for producing the same
MX2009001983A (es) Compuesto que contiene dioxido de titanio.
WO2010013224A3 (en) Curcumin nanoparticles and methods of producing the same
EP1980578A4 (en) METHOD FOR THE PRODUCTION OF A MODIFIED PROPYLENE POLYMER, MODIFIED PROPYLENE POLYMER DERIVED FROM THIS PREPARATION METHOD AND COMPOSITION WITH THE MODIFIED PROPYLENE POLYMER
EP2194093A4 (en) RESIN COMPOSITION, MOLDING RESIN COMPOSITION PREPARED THEREFROM, LAMINATE AND METHOD FOR MANUFACTURING LAMINATES
WO2010123534A3 (en) Enzyme-based nanoscale decontaminating composites
WO2012066059A3 (de) Verfahren zur biokatalytischen cyclisierung von terpenen und darin einsetzbare cyclase-mutanten
WO2010102778A3 (de) Substituierte 3-aminoisoxazolopyridine als kcnq2/3 modulatoren
WO2008140641A3 (en) Pure paliperidone and processes for preparing thereof
WO2010041242A3 (en) Oxidized thiophospholipid compounds and uses thereof
WO2010111659A8 (en) Tumor-initiating cells and methods for using same
HK1147507A1 (en) Process for the preparation of branched polybutadiene with a high content of 1,4-cis units
WO2009130604A3 (en) Solid state forms of deferasirox salts and process for the preparation thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10729092

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2011544776

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 1452/MUMNP/2011

Country of ref document: IN

REEP Request for entry into the european phase

Ref document number: 2010729092

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2010729092

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20117018246

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13143830

Country of ref document: US